Modern Approaches to Optimization of the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency

Main Article Content

S.M. Tkach
O.V. Shvets


The article describes the etiology and current diagnostic methods of investigation of exocrine pancreatic insufficiency, in particular non-invasive 13C-mixed triglyceride test, allowing not only to determine indirectly the activity of pancreatic lipase in the duodenum, but also to evaluate the effectiveness of hormone replacement therapy. Comparative clinical study has been carried out, its main objective was clarifying opportunities for application of 13C-triglyceride breath test to optimize the diagnosis and correction of exocrine pancreatic insufficiency. The efficacy of oral enzyme replacement therapy using drug Pangrol® 25000 was evaluated.

Article Details

How to Cite
Tkach, S., & Shvets, O. (2014). Modern Approaches to Optimization of the Diagnosis and Treatment of Exocrine Pancreatic Insufficiency. GASTROENTEROLOGY, (1.51), 49–54. (51).2014.81912
Original Researches


Burton F., Alkaade S., Collins D. et al. Use and perceived effectiveness of non-analgesic medical therapies for chronic pancreatitis in the United States // Aliment. Pharmacol. Ther. — 2011. — 33. — 149-159.

De-Madaria E., Abad-González A., Aparicio J.R. et al. Spanish Pancreatic Club recommendation on diagnostic and treatment of chronic pancreatitis // Pancreatology. — 2013. — 13. — 18-28.

Dominguez-Munoz J.E., Iglesias-Garcia J., Vilarino-Insua M., Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis // Clin. Gastroenterol. Hepatol. — 2007. — 5. — 484-8.

Dominguez-Munoz J.E., Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? // JOP. — 2010. — 11. — 158-62.

Giuliano S.A., Dehoorne-Smith M.L., Kale-Pradhan P.B. Pancreatic enzyme products // Ann. Pharmaсother. — 2011. — 45. — 658-666.

Fieker A., Philpott J., Armand M. Enzyme replacement therapy for pancreatic insufficiency: present and future // Clin. Exp. Gastroenterol. — 2011. — 4. — 55-73.

Forsmark C. Management of Chronic Pancreatitis // Gastroenterology. — 2013. — 144. — 1282-1291.

Frulloni L., Falconi M., Gabbrielli A., Gaia E., Graziani R., Pezzilli R. et al. Italian consensus guidelines for chronic pancreatitis // Dig. Liver Dis. — 2010. — 42(Suppl. 6). — S381-406.

Kadiyala V., Suleiman S., Conwell D. Pancreatic exocrine insufficiency // Gastroentero&Endoscopy News. — June 2012. — 1-11.

Lohr J.-M. Exocrine Pancreatic Insufficiency. — Bremen: UNI-MED, 2010. — 91 p.

Maguiness K., Fulton J., Luder E. et al. Nutrition: Pancreatic Enzyme Replacement in Patients with Cystic Fibrosis. —

Volume 2012. — 2006.

Safdi M., Bekal P.K., Martin S., Saeed Z.A., Burton F., Toskes P.P. The effects of oral pancreatic enzymes on steatorrhea: a multicenter, placebo-controlled, parallel group trial in subjects with chronic pancreatitis // Pancreas. — 2006. — 33. — 156-62.

Shafiq N., Rana S., Bhasin D., Pandhi P., Srivastava P., Sehmby S.S. et al. Pancreatic enzymes for chronic pancreatitis // Cochrane Database Syst. Rev. — 2009: CD006302.

Stallings V.A., Stark L.J., Robinson K.A. et al. Evidence-based practical recomendations for nutritionrelated management of children and adults with cystic fibrosis and pancreatic insufficiency: results of systematic review // J. Am. Diet. Assoc. — 2008. — 108. — 832-839.

Taylor J.R., Gardner T.B., Waljee А.K., DiMagno M.J., Schoenfeld P.S. Systematic review: efficacy and safety of pancreatic enzyme supplements for exocrine pancreatic insufficiency // Aliment. Pharmacol. Ther. — 2010. — 31. — 57-72.

Toouli J., Biankin A.V., Oliver M.R. et al. Management of pancreatic exocrine insufficiency: Austral-Asian Pancreatic Club recommendations // Med. J. Austr. — 2010. — 193. — 461-467.

Waljee A.K., Dimagno M.J., Wu B.U., Schoenfeld P.S., Conwell D.L. Systematic review: pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis // Aliment. Pharmacol. Ther. — 2009. — 29. — 235-46.

Whitcomb D.C., Yadav D., Slivka A. et al. Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2) // Pancreatology. — 2008. — 8. — 520-31.

Whitcomb D.C., Lehman G.A., Vasileva G., Malecka-Panas E., Gubergrits N., Shen Y. et al. Pancrelipase delayed-release capsules for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: a double-blind randomized trial // Am. J. Gastroenterol. — 2010. — 105. — 2276-86.

Most read articles by the same author(s)

1 2 > >>